Search

The aim of this study is to provide a comprehensive review of the current therapeutic approaches to severe burn injuries. The study will cover the epidemiology of burn injuries, treatment options and adjunctive therapies. It will also emphasize the importance of a multidisciplinary approach in treatment options and discuss current challenges and future directions for research in the treatment of burns. This study aims to provide updated, evidence-based information and guidelines for medical professionals involved in the management of severe burn injuries, and to improve care and outcome for patients affected by these injuries. The WHO states that burn injuries are a major public health concern worldwide, with an estimated 180,000 deaths annually, with the majority of these deaths occurring in low- and middle-income countries. [ABSTRACT FROM AUTHOR]

Because Systemic Lupus Erythematosus (SLE) is a rare disease, and due to the significant prognostic impact of early management, a diagnosis confirmed by a physician with experience in SLE is recommended, for example from an expert center. Once the diagnosis is confirmed, existing manifestations should be identified in particular, renal involvement by an assessment of proteinuria, disease activity and severity should be determined, potential complications anticipated, associated diseases searched for, and the patient's socioprofessional and family context noted. Therapeutic management of SLE includes patient education on recognizing symptoms, understanding disease progression as well as when they should seek medical advice. Patients are informed about routine checkups, treatment side effects, and the need for regular vaccinations, especially if they are receiving immunosuppressive treatment. They are also advised on lifestyle factors such as the risks of smoking, sun exposure, and dietary adjustments, especially when they are receiving corticosteroids. The importance of contraception, particularly when teratogenic medications are being used, and regular cancer screening are emphasized. Support networks can help relieve a patient's isolation. The first-line medical treatment of SLE is hydroxychloroquine (HCQ), possibly combined with an immunosuppressant and/or low-dose corticosteroid therapy. The treatment of flares depends on their severity, and typically involves HCQ and NSAIDs, but may be escalated to corticosteroid therapy with immunosuppressants or biologic therapies in moderate to severe cases. Because there is no curative treatment, the goals of therapy are patient comfort, preventing progression and flares, and preserving overall long-term health and fertility. The frequency of follow-up visits depends on disease severity and any new symptoms. Regular specialized assessments are necessary, especially when treatment changes, but a frequency of every 3 to 6 months is recommended during periods of remission and monthly during active or severe disease, especially in children. These assessments include both clinical and laboratory tests to monitor complications and disease activity, with specific attention to proteinuria. [ABSTRACT FROM AUTHOR]

Our aims were to assess cognitive impairment in bipolar patients in remission compared with healthy controls, and to study its connection to clinical and therapeutic factors. This was a case-control study of patients with bipolar disorder (BD) in remission and matched healthy controls. It was carried out at the Hédi Chaker University Hospital in Sfax, Tunisia. The Screen for Cognitive Impairment in Psychiatry (SCIP) scale was used to assess cognitive function in patients and controls. This scale comprises subtests for verbal learning with immediate (VLT-I) and delayed (VLT-D) recall, working memory (WMT), verbal fluency (VFT) and information processing speed (PST). We recruited 61 patients and 40 controls. Compared with controls, patients had significantly lower scores on the overall SCIP scale and on all SCIP subtests (p < 0.001 throughout) with moderate to high effects. In multivariate analysis, the presence of psychotic characteristics correlated with lower scores on the overall SCIP (p = 0.001), VLT-I (p = 0.001) and VLT-D (p = 0.007), WMT (p = 0.002) and PST (p = 0.008). Bipolar II correlated with lower LTV-I scores (p = 0.023). Age of onset and duration of the disorder were negatively correlated with PST scores (p < 10−3 and p = 0.007, respectively). Predominantly manic polarity correlated with lower VFT scores (p = 0.007). Our study showed that bipolar patients in remission presented significantly more marked cognitive impairments, affecting various cognitive domains, than the controls. These cognitive impairments appear to be linked to clinical and therapeutic factors that are themselves considered to be factors of poor prognosis in BD. [ABSTRACT FROM AUTHOR]

Over the last decades, the use of artificial intelligence, machine learning and deep learning in medical fields has skyrocketed. Well known for their results in segmentation, motion management and posttreatment outcome tasks, investigations of machine learning and deep learning models as fast dose calculation or quality assurance tools have been present since 2000. The main motivation for this increasing research and interest in artificial intelligence, machine learning and deep learning is the enhancement of treatment workflows, specifically dosimetry and quality assurance accuracy and time points, which remain important time-consuming aspects of clinical patient management. Since 2014, the evolution of models and architectures for dose calculation has been related to innovations and interest in the theory of information research with pronounced improvements in architecture design. The use of knowledge-based approaches to patient-specific methods has also considerably improved the accuracy of dose predictions. This paper covers the state of all known deep learning architectures and models applied to external radiotherapy with a description of each architecture, followed by a discussion on the performance and future of deep learning predictive models in external radiotherapy. [ABSTRACT FROM AUTHOR]

Copyright of Physiotherapy Canada is the property of University of Toronto Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Les gastro-entérites sont le plus souvent d'origine virale, rotavirus et norovirus étant les virus les plus fréquemment en cause chez les jeunes enfants. Les PCR multiplex effectuées à partir des selles permettent de détecter des bactéries, des virus ou des parasites responsables ou non de la gastro-entérite. Si le profil étiologique de ces infections digestives a grandement bénéficié de la PCR, la présence de pathogènes potentiels ne justifie pas de traitement anti-infectieux en dehors de pathologies sous-jacentes. En effet, parmi les causes bactériennes, très peu nécessitent un traitement antibiotique en dehors des shigelloses, des formes graves de salmonellose et une partie des infections à Campylobacter sp. L'évolution de la résistance aux antibiotiques des salmonelles, shigelles et campylobacter est préoccupante dans le monde, limitant les options thérapeutiques. Les antibiotiques proposés dans ce guide sont en accord avec les recommandations communes de l'European Society of Pediatric Infectious Diseases et l'European Society of Pediatric Gastroenterology and Nutrition. L'azithromycine est préférentiellement utilisée pour traiter les infections à Shigella sp. ou à Campylobacter sp. La ceftriaxone et la ciprofloxacine sont recommandées pour traiter les salmonelloses nécessitant une antibiothérapie. Les traitements empiriques, sans identification bactérienne, ne sont pas indiqués en dehors d'un sepsis sévère ou chez des sujets à risque (drépanocytose par exemple). La prescription de métronidazole pour une amibiase intestinale aiguë ne doit être faite qu'après confirmation microbiologique. Gastroenteritis is usually due to viruses mainly Rotavirus and Norovirus. Among the bacterial causes, very few warrant systemic antibiotic treatment including Shigella , Vibrio cholerae , Campylobacter (only if diagnosed early) and severe cases of Salmonella infections. The antimicrobial treatments proposed in this guide are consistent with the latest recommendations of the European Society of Pediatric Infectious Diseases and the European Society of Pediatric Gastroenterology and Nutrition. Azithromycin is the preferred antibiotic for infections due to Shigella and Campylobacter. Ceftriaxone and ciprofloxacin are recommended for Salmonella infections that must be treated. Empirical treatment without bacteriological documentation should be avoided. The prescription of metronidazole for acute intestinal amebiasis should only be made after microbiological confirmation. [ABSTRACT FROM AUTHOR]

Electrical burn injuries (EBI) affect both adults and children and are responsible for a very high number of major limb amputations. Their management is still a major challenge. This retrospective review concerns 42 children, admitted to an intensive burn care department in Tunisia for high electrical burns, from January 2016 to September 2022. The average age of our patients was 12 years, with a male predominance (90.5%). Electrotrauma was accidental in the majority of cases (93%) and secondary to a domestic accident in 54.8% of cases. Total body surface area was 19%. Burns were second degree in 2/3 of cases and third degree in 1/3 of cases. The most affected areas were distal extremities in 2/3 of the cases. Rhabdomyolysis was observed in 93% of cases and troponins were elevated in half of the patients. Escharotomy was required in 38% of cases. Amputation was performed in 18 children (43%): one limb (n=10); 2 limbs (n=6) and 3 limbs (n=2). The outcome was favorable in 9 children (21.4%); functional and cosmetic sequelae with an impact on schooling and psychology were reported in 25 cases. Mortality was 16.7%. [ABSTRACT FROM AUTHOR]

Diabetes causes peripheral neuropathy with loss of sensitivity of feet to pain, predisposing diabetic patients to a high risk of severe burns. Our retrospective study aimed to look at epidemiological, clinical, therapeutic and outcome characteristics of feet burns occurring in patients with diabetes, hospitalized in the burn trauma center of Tunis over 4 years (from 2019 to 2022). We included 34 patients, among which 9 had only feet burns. Their mean age was 60 years (range: 41-83 years), with male predominance (sex ratio = 1.83). A quarter of patients (n=9) were on oral antidiabetic drugs (OADs) and more than half (n=18) were at the stage of degenerative complications. At admission, blood glucose level was higher than 10 mmol/l in 73% of patients. TBSA was 19%. Twenty-two patients had deep feet burns, among which 5 patients underwent aponerrotomy for deep, circular burns. Amputation was done in 15 patients: toes (n=9), one limb (n=3) and two limbs (n=3). Duration of ICU stay was 18.3 days and mortality was 20.58%. [ABSTRACT FROM AUTHOR]

Pancreatic neuroendocrine tumours (PanNETs) are rare malignancies, but their incidence is increasing. Although about 50% of PanNETs are associated with metastases, mainly hepatic, they are associated with a relatively favourable prognosis (50% to 75% 5-year survival rate) due to their relatively slow growth. Metastatic PanNETs are most often sporadic and diagnosed incidentally or in the presence of nonspecific clinical signs related to tumour locations. Symptoms related to the hypersecretion of a hormone by functional PanNETs are present in less than 20% of cases but should be treated as a priority. The extension work-up is based on thoraco-abdominopelvic CT scan, liver MRI and 68Ga-DOTATOC-PET/CT, possibly supplemented by FDG PET. The choice of treatment is based on prognostic markers (histoprognostic grade, metastatic extension, progressive slope, resectability) and rare predictive markers (MGMT status, somatostatin receptor expression). Complete resection of metastases is the standard treatment if feasible. Otherwise, treatment options include chemotherapy, targeted therapies (sunitinib, everolimus), somatostatin analogues, hepatic chemoembolization, and peptide-receptor radionuclide therapy. The choice of the best therapeutic strategy in patients with metastatic PanNETs is complex and should be systematically discussed during multidisciplinary tumour boards. [ABSTRACT FROM AUTHOR]

Télémédecine (TLM) et télépsychothérapie (TLPT) se développent depuis plus d'une dizaine d'années à travers le monde mais les évaluations de cette nouvelle modalité de soin sont encore trop rares. Ce changement de cadre thérapeutique est-il satisfaisant ? Les résistances à cette évolution se situent-elles du côté du praticien ou du patient ? Le COVID-long, pathologie chronique apparue après la crise sanitaire de 2020, peut-il bénéficier de cette forme de thérapie ? C'est l'une des questions à laquelle cet article tente de répondre. Structuré en deux parties, cet article présente tout d'abord une revue détaillée des travaux passés et actuels en télépsychiatrie (TLP) et TLPT. Puis, les auteurs explorent des pistes de prise en charge de la symptomatologie psychopathologique du COVID-long, qui se caractérise essentiellement par des troubles anxiodépressifs ainsi qu'un état de stress post-traumatique (ESPT). La pluridisciplinarité s'impose dans la prise en charge du COVID-long. Thérapie cognitivo-comportementale (TCC) et psychothérapie interpersonnelle (IPT) se dégagent en tant que méthodes de traitement efficaces pour les troubles psychopathologiques. La réalité virtuelle ainsi que la réalité augmentée semblent également indiquées dans les TLPT des syndromes post-traumatiques. Quels que soient le modèle théorique sous-jacent aux actes et les modalités de la TLPT, ce dispositif exige l'acceptation du cadre sans réticence. Le changement de cadre est à prendre en considération, mais la qualité de l'alliance thérapeutique semble renforcée par l'aspect rassurant des consultations depuis le lieu de vie habituel du patient, et au-delà des thérapies en « visio », les thérapies épistolaires par échanges de courriers électroniques semblent particulièrement intéressantes. Telemedicine and virtual psychotherapy have been developing worldwide for over a decade, but evaluations of this new treatment modality are still too rare. Is this evolution in therapeutic treatment protocols satisfactory? Does resistance to this development come from the practitioner or the patient? Can long-term COVID, a chronic pathology that emerged after the pandemic of 2020, benefit from this approach to therapy? This article seeks to answer that question. Structured in two parts, this article first presents a detailed review of past and current work on telemedicine, and virtual psychotherapy. In the second part, the authors explore ways of treating the psychopathological symptomatology of long COVID, which is essentially characterized by anxiety-depressive disorders as well as post-traumatic stress disorder (PTSD). Multidisciplinarity is essential in the management of long COVID. Cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT) have proved to be effective treatment methods for the psychopathological disorders inherent in long COVID. Virtual reality, as well as augmented reality, also seems to be indicated as effective in virtual psychotherapy treatment of post-traumatic stress disorder (PTSD). Whatever the theoretical model underlying the actions and methods of virtual psychotherapy, it is important to accept without hesitation the framework. It would appear that the transferential and counter-transferential components of therapeutic relationships are not affected by the change of setting. The quality of the therapeutic alliance is strengthened by the reassuring aspect of consultations from the patient's usual place of residence. In addition to videoconference therapies, epistolary therapies using email exchanges seem also to be particularly interesting. [ABSTRACT FROM AUTHOR]

Fat-soluble vitamins, including vitamins A, D, E and K, are molecules with no energy value that are essential for the body to function and for life. Their intake is almost exclusively exogenous, i.e. dietary. The ubiquitous and vital nature of the functions performed by these vitamins explains the wide variety of clinical manifestations and their potential seriousness, particularly in cases of deficiency, but also in cases of excess or hypervitaminosis. We present here the main symptoms of hypervitaminosis. [ABSTRACT FROM AUTHOR]

Fat-soluble vitamins, including vitamins A, D, E and K, are molecules with no energy value that are essential for the body to function and for life. Their intake is almost exclusively exogenous, i.e. dietary. As a result, deficiencies in fat-soluble vitamins are rarer in industrialised countries than in countries with limited resources. However, even in the latter, certain groups of individuals are affected, such as newborns or growing children, pregnant or breast-feeding women and elderly or isolated subjects. Vitamin A, D, E and K deficiencies are also relatively common in people with digestive tract disorders, in patients suffering from chronic pathologies or in intensive care patients. Deficiencies or excesses of fat-soluble vitamins are responsible for a variety of more or less specific clinical symptoms. Treatment of deficiencies requires vitamin supplementation, a well-balanced diet and treatment of the cause. [ABSTRACT FROM AUTHOR]

Le syndrome de Willebrand acquis est un trouble rare de la coagulation se développant chez des patients sans antécédents personnels et familiaux de saignement, dont les caractéristiques cliniques et biologiques sont similaires à ceux des formes constitutionnelles. Il a été le plus souvent signalé chez des patients présentant diverses maladies sous-jacentes, notamment une gammapathie monoclonale, des troubles lymphoprolifératifs, des syndromes myéloprolifératifs ou des maladies auto-immunes. Chez les patients présentant des saignements d'apparition récente, des examens cliniques et biologiques approfondis sont nécessaires pour en déterminer la cause sousjacente. Le syndrome de Willebrand acquis est potentiellement grave. Il doit être évoqué chez l'adulte devant un syndrome hémorragique cutanéomuqueux inhabituel avec ou sans allongement du temps de céphaline avec activateur et confirmé par le dosage de l'activité et de l'antigène du facteur de von Willebrand. Une maladie associée hématologique, néoplasique ou valvulaire cardiaque doit être recherchée. Le traitement substitutif ne donne pas toujours de bons résultats, seul le traitement de l'affection sous-jacente, lorsqu'il est possible, permet dans certains cas de corriger le syndrome de Willebrand acquis. Nous présentons ici un cas de déficit acquis majeur en facteur de Willebrand secondaire à un myélome multiple à IgG Kappa chez un patient de sexe masculin. Acquired Willebrand syndrome is a rare coagulation disorder developing in patients without a personal and family history of bleeding, whose clinical and biological characteristics are similar to those of constitutional forms. It has been most commonly reported in patients with a variety of underlying diseases, including monoclonal gammopathy, lymphoproliferative disorders, myeloproliferative syndromes, or autoimmune diseases. In patients with new onset bleeding, thorough clinical and laboratory investigations are necessary to determine the underlying cause. Acquired Willebrand syndrome is potentially serious. It should be consideredin adults when faced with an unusual mucocutaneous hemorrhagic syndrome with or without prolongation of the partial thromboplastin time with activator and confirmed by the determination of von Willebrand factor activity and antigen. An associated hematological, neoplastic or cardiac valve disease should be sought. Substitution treatment does not always give good results; only treatment of the underlying condition, when possible, allows in certain cases to correct acquired Willebrand syndrome. We present here a case of major acquiredWillebrand factor deficiency secondary to IgG Kappa multiple myeloma in a male patient. [ABSTRACT FROM AUTHOR]

Objectives: Many people who are diagnosed with bipolar disorder also have comorbid personality disorder. Few studies have explored how personality disorder may influence pharmacological treatment outcomes. The aim of this study was to conduct a secondary analysis of data from a clinical trial of adjunctive nutraceutical treatments for bipolar depression, to determine whether maladaptive personality traits influence treatment outcomes. Methods: Scores on the Standardised Assessment of Personality – Abbreviated Scale screener were used to classify participants as having bipolar disorder with (n = 119) and without (n = 29) above threshold personality disorder symptoms (personality disorder). Outcome measures included: The Montgomery Åsberg Depression Rating Scale, Clinical Global Impressions and Improvement Severity Scales, Patient Global Impressions–Improvement scale, Bipolar Depression Rating Scale, Range of Impaired Functioning Tool, Social and Occupational Functioning Assessment Scale and Quality of Life and Enjoyment Scale (Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form). Generalised estimated equations examined the two-way interactions of personality disorder by time or treatment and investigated personality disorder as a non-specified predictor of outcomes. Results: Over time, the Patient Global Impressions–Improvement scores were significantly higher in those in the personality disorder group. No other significant differences in the two-way interactions of personality disorder by treatment group or personality disorder by time were found. Personality disorder was a significant but non-specific predictor of poorer outcomes on the Bipolar Depression Rating Scale, Range of Impaired Functioning Tool, and Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form, regardless of time or treatment group. Conclusions: This study highlights the potential impact of maladaptive personality traits on treatment outcomes and suggests that the presence of comorbid personality disorder may confer additional burden and compromise treatment outcomes. This warrants further investigation as does the corroboration of these exploratory findings. This is important because understanding the impact of comorbid personality disorder on bipolar disorder may enable the development of effective psychological and pharmacotherapeutic options for personalised treatments. [ABSTRACT FROM AUTHOR]

Introduction: Breast cancer is one of the main causes of morbidity and mortality in Africa and Mali and its prognosis remains serious with very low survival. We initiated this study to determine the overall and specific survival rate by treatment type. Patients and Methods: This was a cross-sectional study from January 1, 2016 to October 31, 2021. It concerned all women who had been seen in the obstetric gynecology department of the teaching hospital Luxembourg in Bamako during the study period. We conducted a multivariate analysis of the factors influencing survival after logistic regression according to the Cox model. Results: We recorded 70 cases of breast cancer among 41613 gynecological consultations or 0.16%. Over the months there is a very rapid decrease in survival. The chemotherapy improves survival, surgery and radiotherapy greatly contribute to the improvement. Concerning hormone therapy, it protects subjects with a statistically significant probability (P < 0,05). Conclusion: Breast cancer survival remains very low in the department, the need for well-organized screening campaigns and early and multidisciplinary case management. [ABSTRACT FROM AUTHOR]

Le syndrome douloureux régional complexe de type I, SDRC I du pied et de la cheville, anciennement appelé algodystrophie, est une affection douloureuse polymorphe articulaire et périarticulaire pouvant atteindre le pied et la cheville. Les symptômes cliniques se caractérisent par une douleur souvent mal systématisée, accompagnée de troubles de la sensibilité, vasomoteur, sudoromoteur, musculaire et trophique locaux, à extension possible régionale, survenant dans les suites d'un traumatisme, même mineur, ou spontanément. Malgré les avancées dans sa compréhension, la physiopathologie demeure partiellement élucidée, suggérant des altérations complexes au niveau du système nerveux sympathique, du système nerveux central ainsi que des phénomènes inflammatoires locaux. L'évolution est imprévisible dans le temps, et peut entraîner un handicap fonctionnel parfois sévère ainsi qu'une altération de la qualité de vie. Le diagnostic est avant tout clinique. Il existe un consensus pour utiliser les critères de Budapest pour le diagnostic de SDRC I permettant d'uniformiser la pratique clinique quotidienne. Le traitement repose avant tout sur la réadaptation fonctionnelle. D'autres options thérapeutiques, notamment l'administration de bisphosphonates par perfusion, sont envisageables selon les cas, en prenant en compte les différents symptômes, la sévérité du handicap fonctionnel et les contraintes spécifiques de prise en charge. The complex regional pain syndrome type I, CRPS I in the foot and ankle, also known as algodystrophy, is a polymorphous pain articular and peri-articular condition. It is characterized by poorly systematized neuropathic regional pain, accompanied by sensory, vasomotor, sudomotor, muscular and trophic disorders. It is often triggered by a traumatic event (fracture, sprain, surgery). Despite advances in our understanding of its pathophysiology, it remains only partially elucidated, suggesting complex alterations in the sympathetic and central nervous systems, as well as local inflammatory phenomena. Its risk is prolonged evolution, leading to joint stiffening and functional disability. Diagnosis is primarily clinical, supported by Budapest criteria. Treatment is primarily based on rehabilitation. Analgesics are used to make rehabilitation tolerable and acceptable. Other treatment options, such as infusion of bisphosphonates, may be considered on a case-by-case basis, taking into account the stage of the disease, the severity of functional impairment and specific management constraints. [ABSTRACT FROM AUTHOR]

Deep periorbital burns are an important issue mainly due to the presence of the eyes in the region, and the crucial importance of preservation of vision. There is no consensus regarding their treatment. A retrospective analysis of the treatment and outcome of 446 patients with deep burns of the periorbital region admitted to the Department of Burns and Plastic Surgery of St George's University Hospital in Plovdiv, Bulgaria over 10 years was conducted. The study covers 446 patients, 162 female (36.5%) and 284 male (63.5%) aged from 5 months to 92 years. Deep periorbital burns accounted for 74.8% of hospitalized deep facial burns. Most frequent burn agents were hot liquids and flames. The mean total body surface area affected was 19.6% (min 0.5%, max 80.0%). Concomitant ocular pathology was diagnosed in 14% (n=63) of the patients. An early, staged and precise surgical approach was preferred, aimed at fast wound closure without sacrificing survived tissues. Follow up time ranged from 3 months to 5 years, median 37 months. Late ocular sequelae occurred in 7.4% (n=33) of the patients. There was no incidence of secondary corneal perforation or definitive loss of vision. Timely and adequate treatment during the acute period can minimize initial damage and late sequelae. Favor is given to the early, balanced surgical approach aimed at rapid wound closure between day 2 and 10 post burn. Preservation of vision is a determining factor for the significance of trauma and the effectiveness of treatment. [ABSTRACT FROM AUTHOR]

La sclérodermie systémique (ScS) est une connectivite rare caractérisée par de l'inflammation, de la fibrose, et de l'auto-immunité. Parent pauvre de la recherche clinique pendant plusieurs années comparativement aux autres maladies auto-immunes, la ScS a bénéficié d'un regain d'intérêt depuis une dizaine d'années et de très nombreux essais cliniques sont en cours. Nous présentons ici les résultats des essais publiés dans les 5 dernières années au cours de la ScS en fonction des critères de jugements choisis et décrivons les essais en cours ou attendus dans les années à venir. Systemic sclerosis (SSc) is a rare connective tissue disease characterized by inflammation, fibrosis, and autoimmunity. Despite few clinical trials when compared to other autoimmune diseases, SSc has benefited from renewed interest over the past ten years and a large number of clinical trials have been performed or are underway. We present here the results of the trials published in the last 5 years in ScS according to the chosen endpoint criteria and describe the trials in progress or expected in the years to come. [ABSTRACT FROM AUTHOR]

Prosthetic joint infection (PJI) is a devastating complication that can occur following hip arthroplasty. We report the technical therapeutic adaptations and results of a short case series of hip PJI at the Yaoundé General Hospital (YGH), Cameroon. All patients admitted and treated for PJI at the YGH from January 2020 to December 2022, and followed-up for at least one year, were included in this retrospective study. The primary endpoint was the rate of persistence of infection or recurrence of infection at a minimum follow-up of one year. The secondary endpoints were the rate of reoperation of the same hip, loosening, mortality, Postel Merle d'Aubigné (PMA) functional score. In total, 8 patients presenting 9 episodes of PJI were included. PJI occurred early in 4 cases, delayed in 2 cases, and late in 3 cases. All patients received surgical treatment associated with probabilistic antibiotic therapy, then adapted to bacterial culture for at least 6 weeks. The techniques performed were debridement and implant sterilization (DAIS) then reimplantation in a single surgery in 4 cases, debridement and implant retention (DAIR) in 1 case, debridement and implant exchange (DAIEX) in one stage in 1 case, the DAIEX in 2 stagesin 1 case and debridement and implant removal (Girdlestone intervention) in 02 cases. Apart from the patient treated with DAIR who evolved toward persistence of PJI, then successfully managed secondarily by DAIS, infection was controlled in all patients at a median follow-up of 26 months. No patient has required re-operation on the same hip during followup to date. Two cases of death were observed during the follow-up period. The functionalresult was satisfactory, with a median PMA score of 15 (11- 17) and all patientssaid they were very satisfied with the treatment of their PJI. Thisshort case seriesfinds that the treatment of hip PJI by DAIS, DAIEX, and Girdlestone gives good results in our environment. In limited-resources settings where it is not always possible for a patient who developed PJI to purchase a new prosthesis, DAIS seems to be a relevant and reliable alternative [ABSTRACT FROM AUTHOR]

Oral ulcerations caused by aphtous lesions, leukoplakia, scarlet fever, syphilis, NOMA, mucormycosis herpetic lesions, candidiasis, discoid lupus erythematous, ulcerative lichen planus, mucous membrane pemphigoid, spongy nevus, oral submoucs fibrosis and pemphigus vulgaris are treated in a step-up fashion that may include topical, intralesional, and systemic pharmaceutical treatment. This page discusses the most often used therapy agents, methods, and dosages. Although the emphasis is on local pharmacologic therapy, systemic illnesses that frequently occur with such oral lesions are briefly discussed, as is the appropriate care. [ABSTRACT FROM AUTHOR]

Osteoid osteoma is a benign osteogenic tumour traditionally treated by surgical excision or percutaneous CT-guided procedures. We describe three cases of osteoid osteomas of which the locations were difficult to access, or for which the procedure was potentially unsafe, involving treatment with zoledronic acid infusions. We report here three male 28 to 31-year-old patients with no medical history who had osteoid osteomas located at the second cervical vertebra, the femoral head, and the third lumbar vertebra respectively. These lesions were responsible for inflammatory pain requiring daily treatment with acetylsalicylic acid. Given the impairment risk, all of the lesions were ineligible for surgical or percutaneous treatment. Patients were successfully treated by 3 to 6 monthly zoledronic acid infusions. All patients experienced complete relief of their symptoms allowing aspirin discontinuation, without any side effects. In the first two cases, CT and MRI control showed nidus mineralization and bone marrow oedema regression, correlating with the pain decrease. After 5 years of follow-up there had been no recurrence of the symptoms. Monthly 4 mg zoledronic acid infusions seem to be safe and effective in the treatment of inaccessible osteoid osteomas. [ABSTRACT FROM AUTHOR]

Copyright of Recherches en Sciences de Gestion is the property of ISEOR and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Cette étude qui renvoie spontanément à une science de la nature, abrite une dimension sociale qui la fait accepter dans cette revue de la dynamique sociale car touchant à la dimension socio environnementale liée à la protection de la santé communautaire ou publique. En effet, dans le cadre de la technique de recyclage artisanal à chaud des thermoplastiques (PEBD, PEHD et PET) pour lutter contre la pollution plastique dans la ville de Kinshasa, il est important d'apporter d'autres mesures pour lutter contre les méfaits provenant de cette technique : la pollution atmosphérique générée par l’émission de la fumée issue de la fusion des déchets thermoplastiques dans la marmite et l’exposition du personnel travaillant à l’inhalation des gaz toxique et donc éléments toxiques s’il n’est pas protégé. Voilà le pourquoi de cette étude qui vise à tester l'efficacité d'un dispositif filtrant pour épurer les fumées issues de la fusion des déchets thermoplastiques pour la fabrication d'autres matériaux plastiques (pavés). Un capteur de gaz "Grove - VOC and eCO2 Gas Sensor : SGP30" connecté à un ordinateur est placé à la partie d'extraction et d'évacuation des fumées. Pendant 5 minutes, nous avons échantillonné à 25%, 50%, 75% et 100%, le nombre de COV et d'eCO2 contenus dans cette fumée avant et après son passage à travers le filtre constitué de compost organique. Le capteur de gaz "Grove - VOC and eCO2 Gas Sensor : SGP30" a compté 60000 COV avant et 18206 après le passage de la fumée dans le filtre. Pour l'eCO2, 57230 particules sont comptées avant et 54772 après le passage de la fumée à travers le filtre. Les résultats obtenus indiquent que le dispositif filtrant est efficace à 69,7% pour l'absorption des COV et moins efficace à 4,3% pour l'eCO2. Cette technique mérite une considération particulière pour l'assainissement de la ville de Kinshasa contre la pollution atmosphérique et plastique.

Les tumeurs du sein sont les tumeurs les plus fréquentes chez la femme, mais représentent un groupe très hétérogène. D'une part, il existe les carcinomes canalaires et lobulaires du sein, représentant 90 % des tumeurs, dont les caractéristiques cliniques et pathologiques sont bien connues. D'autre part, il y a les tumeurs rares du sein, dont chacune représente moins de 1 %, rendant plus difficile leur étude à travers de larges séries. L'objectif de ce travail était de collecter, mettre à jour et synthétiser les connaissances portant sur ces tumeurs rares. Une revue de la littérature a été effectuée sur les bases de données Medline et Google Scholar. Nous présentons ici une sélection de plusieurs tumeurs rares, en apportant des données actualisées aux niveaux épidémiologiques, histopathologiques, génétiques, cliniques et radiographiques, pronostiques et thérapeutiques en prenant en compte la place de la radiothérapie. Chaque histologie tumorale est singulière et possède des caractéristiques propres, la prise en charge doit donc être adaptée et discutée en réunion de concertation pluridisciplinaire. Breast tumours are the most common tumours in women but represent a very heterogeneous group. On the one hand, there are ductal and lobular carcinomas of the breast, representing 90% of tumours, whose clinicopathologic characteristics are well known. On the other hand, there are rare breast tumours, each of which represents less than 1% that limits their study through large cohorts. The objective of this work was to collect, update and synthesize knowledge on these rare tumours. A literature review was performed on the Medline and Google Scholar databases. We present here a selection of several rare tumours, providing updated data at the epidemiological, histopathological, genetic, clinical and radiographic, prognostic and therapeutic levels, taking into account the place of radiotherapy. Each tumour histology is unique and has its own characteristics, the management must therefore be adapted as much as possible and decided in a multidisciplinary meeting. [ABSTRACT FROM AUTHOR]

La maladie de Kawasaki (MK) est la vascularite la plus fréquente chez l'enfant de moins de 5 ans. Elle constitue une urgence diagnostique et thérapeutique. Sa gravité est liée à l'atteinte coronarienne qui survient chez 3–5 % des patients traités. Le défi de cette maladie est de deux types : (1) sa reconnaissance rapide, (2) la réduction de l'incidence des anévrismes coronariens (AC). Nous reprenons dans cette revue la prise en charge thérapeutique de cette maladie et notamment l'adjonction dans le cas de MK sévère d'un traitement adjuvant par corticothérapie qui semble réduire l'incidence des AC notamment dans les populations asiatiques. D'autres traitements (anti-TNF, anti-IL-1, ciclosporine) peuvent également apporter un bénéfice, mais les données sont à ce jour limitées et ne permettent pas leur indication en 1re intention mais seulement en cas de MK réfractaires après une ou deux doses d'IgIV. Kawasaki disease (KD) is the most common vasculitis in children under 5 years of age. It is a diagnostic and therapeutic emergency. Its severity is related to its coronary involvement, which occurs in 3–5 % of patients treated. The challenge of this disease is twofold: (1) its rapid recognition, (2) the reduction of the incidence of coronary aneurysm (CA). In this review, we discuss the therapeutic management of this disease and in particular the addition of adjuvant corticosteroid therapy in severe KD, which seems to reduce the incidence of CA, particularly in Asian populations. Other treatments (anti-TNF, anti-IL-1, ciclosporin) may also be of benefit, but the data are scarce and do not allow their indication as first-line treatment but only in cases of refractory MK after one or two doses of IVIG. [ABSTRACT FROM AUTHOR]

La maladie associée aux IgG4 est caractérisée par une ou plusieurs atteintes d'organes pseudotumorales pouvant atteindre virtuellement tous les organes, et partageant des lésions histologiques communes. Dans cette monographie, nous proposons une revue de la littérature synthétisant les différentes atteintes d'organes possibles, les principales caractéristiques biologiques et histologiques retrouvées chez ces patients, ainsi que les critères diagnostiques et de classification à disposition des cliniciens. Un focus est également réalisé sur les exceptionnelles atteintes articulaires de la maladie ainsi que sur les rares formes secondaires/de chevauchement avec d'autres maladies systémiques. Enfin, les récentes avancées dans la compréhension physiopathologique de la maladie sont présentées, ainsi que les principales recommandations et avis d'experts concernant la prise en charge thérapeutique de ces patients. IgG4-related (IgG4-RD) disease is a rare multi-organ fibro-inflammatory condition characterized by mass lesions and strictures, that can affect virtually all organs with characteristic histological lesions. In this review, we purpose an overview of the different organ involvements, biological and histological characteristics of the patients, as well as a literature review on diagnostic and classification criteria available for physicians. A specific focus on anecdotal IgG4-related arthritis/synovitis and rare "secondary" IgG4-RD associated with other systemic immune-mediated conditions is also purposed for rheumatologists. Finally, recent advances on pathophysiology are presented, as well as main expert consensus and recommendations on IgG4-RD management. [ABSTRACT FROM AUTHOR]

Les sclérites et épisclérites sont des maladies inflammatoires oculaires rares mais qui méritent d'être connues des internistes du fait de leur association fréquente à des maladies systémiques auto-immunes ou inflammatoires. Leur distinction par l'interrogatoire et l'examen ophtalmologique est importante car leur prise en charge, leur pronostic et leurs complications potentielles sont très différents. L'épisclérite représente une inflammation oculaire superficielle, de bon pronostic visuel avec un traitement souvent local, habituellement sans complication. Elle est très rarement associée à une maladie systémique auto-immune. En revanche, la sclérite est une atteinte ophtalmologique potentiellement grave qui peut menacer le pronostic visuel en l'absence de traitement systémique adapté. Elle est associée à une maladie sous-jacente dans 40 à 50 % des cas, en particulier une maladie systémique auto-immune (25 à 35 % des cas) ou une cause infectieuse (5 à 10 % des cas). La polyarthrite rhumatoïde et les vascularites systémiques, en particulier les vascularites associées aux anticorps anti-cytoplasme des polynucléaires neutrophiles (ANCA), sont les principales causes auto-immunes de sclérites et d'épisclérites. Les sclérites peuvent constituer une porte d'entrée révélatrice de la maladie auto-immune sous-jacente et imposent des explorations étiologiques systématiques. Elles nécessitent dans les formes agressives, compliquées, réfractaires ou associées à une maladie systémique auto-immune, le recours à une corticothérapie générale, voire un traitement immunosuppresseur, ainsi qu'une étroite collaboration entre ophtalmologues et internistes. L'avènement des biothérapies offre de nouveaux outils thérapeutiques efficaces dans la prise en charge de ces cas difficiles. Scleritis and episcleritis are rare ocular inflammatory diseases but deserve to be known by internists because of their frequent association with systemic autoimmune diseases. It is important to distinguish them between because their prognosis, therapeutic management and potential complications are very different. Episcleritis represents a superficial ocular inflammation with usually benign visual prognosis, no complication with local treatment, and is associated with a systemic autoimmune disease in rare cases. In contrast, scleritis is a potentially serious ophthalmological condition that can threaten the visual prognosis in the absence of appropriate systemic treatment. It is associated with an underlying disease in 40–50% of cases, in particular a systemic autoimmune disease (25–35% of cases) or an infectious cause (5–10% of cases). Rheumatoid arthritis and systemic vasculitides, particularly antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides, are the main autoimmune causes of scleritis and episcleritis. Scleritis can reveal the underlying autoimmune disease and requires systematic etiological investigations. Aggressive, complicated, refractory forms or those associated with a systemic autoimmune disease require glucocorticoids or even immunosuppressants, and close collaboration between ophthalmologists and internists is required. The development of biologic agents offers new effective therapeutic tools in the management of these difficult cases. [ABSTRACT FROM AUTHOR]

Clostridioides difficile infections (CDI) are a heterogeneous entity with -multiple clinical presentations. The incidence of CDI has significantly increased over the last 30 years with the emergence and dissemination of hypervirulent and -hyperepidemic clones which extend to the community environment. Prevention is based on reducing inappropriate antibiotic consumption, early identification of patients at risk of CDI and those who may progress to severe and/or recurrent forms. Fidaxomicin was an important therapeutic innovation and is now used as first line therapy. Oral metronidazole has no place in current therapeutic algorithms. Finally, fecal microbiota transplantation is today the treatment of choice of the 2nd recurrence. Beztoloxumab can be used in cases of ICD with a high risk of recurrence or first recurrence. [ABSTRACT FROM AUTHOR]

Copyright of Gériatrie et Psychologie Neuropsychiatrie du Vieillissement is the property of John Libbey Eurotext Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Les dispensateurs de soins pédiatriques sont souvent le premier point de contact des enfants et des adolescents aux prises avec des problèmes de santé mentale, mais ils ne possèdent pas nécessairement les ressources (p. ex. l'accès à une équipe multidisciplinaire) ni la formation nécessaires pour procéder à leur dépistage ou à leur prise en charge. Le présent document de principes conjoint décrit les principaux rôles et les principales compétences à maîtriser pour évaluer et traiter les problèmes de santé mentale chez les enfants et les adolescents, de même que les facteurs qui optimisent le plus possible l'évolution de la santé mentale dans ces groupes d'âge. Il contient des conseils fondés sur des données probantes à propos du dépistage des préoccupations en matière de santé mentale chez les jeunes et leur famille ainsi qu'à propos des échanges sur le sujet. Les interventions préventives et thérapeutiques dont l'efficacité est démontrée en milieu communautaire sont abordées. Le présent document de principes, qui est fondamental, traite également des changements à l'enseignement de la médecine ainsi qu'aux systèmes et aux politiques de santé qui s'imposent pour améliorer la pratique clinique et les efforts de revendications au Canada, y compris les modèles de rémunération appropriés, les approches des soins abordées étape par étape, le financement gouvernemental ciblé, l'enseignement et la formation professionnelle. [ABSTRACT FROM AUTHOR]

Psoriasis is a chronic inflammatory skin disease affecting almost 1% of children, starting the first months of life. In some journals, this prevalence is reported to be between 0.4 and 0.7%. We are reporting a case of childhood psoriasis in a 2-year-old patient. The case was observed in the Dermatology unit at the Hubert Koutoukou Maga National University Hospital of Cotonou (CNHU-HKM). The case clinical description will allow us to show the difficulties in establishing a diagnosis and how little are the treatment choices available in our clinical settings. [ABSTRACT FROM AUTHOR]

La clozapine est le traitement de référence dans la schizophrénie résistante. Cette molécule, bien qu'ayant prouvé son efficacité dans de nombreuses études, reste largement sous-prescrite dans son indication principale. La réalisation de programmes d'éducation thérapeutique du patient (ETP) centrée sur cette molécule pourrait permettre, d'une part, de favoriser la prescription de cette molécule et, d'autre part, de favoriser l'adhésion thérapeutique des patients à ce traitement via une meilleure connaissance de celui-ci. Cet article présente le programme d'ETP « Vivre avec la clozapine » élaboré pour l'initiation et le suivi des patients sous clozapine. Clozapine is the reference treatment for resistant schizophrenia. Although its efficacy has been widely demonstrated in numerous studies, it remains largely under-prescribed in its main indication. Therapeutic patient education (TPE) programs focused on clozapine could, on the one hand, promote the prescription of this drug and, on the other, encourage patients to adhere to the treatment schedule by improving their knowledge of its effectiveness. This article presents the TPE program entitled " Living with clozapine " developed to support the initiation and follow-up of patients being treated with clozapine. [ABSTRACT FROM AUTHOR]

For more than 30 years, suicide has been the second cause of death among 15-24 year olds and the 5th cause of death among those under 13. In 2016, 26 deaths by suicide were recorded among those under 15 and 352 among those aged 15-24, i.e. respective rates of 0.3 and 4.5 per 100,000 inhabitants [1]. In a first file [2] we saw the different types of interventions to prevent the risk of suicide among adolescents and the effectiveness of collective prevention approaches. In this second file we address the identification and treatment in general medicine consultation. [ABSTRACT FROM AUTHOR]

Copyright of Drama Therapy Review is the property of Intellect Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

ABSTRACTProduced water contains salts and minerals of sufficiently high content (salinity > 35%) to be harmful to the ecosystem, making it difficult to dispose of, reinject for enhanced oil recovery, or use for other purposes such as human use and agriculture. This research summarises produced water treatment methods and their ranges of applicability and provides a comprehensive review of the most common desalination techniques used globally for high-salinity waters, explaining their mechanism, applications, advantages and limitations. We provide recommendations on the use of different methods for the desalination of hydrocarbon-associated produced water.

Introduction. La revue annuelle de la qualité des produits (RAQP), exigence internationale pour les formes finies et les substances actives, est particulièrement scrutée lors d’inspections et d’audits. Elle s'apparente à une validation rétrospective continue permettant de détecter toute dérive et de s’assurer de la fiabilité des procédés et de la qualité des produits. La RAQP du Gardénal 50mg (Phénobarbital) fabrique sur le site de Dakar en boite de 30 comprimes a porté sur cinq (5) lots Matériels et méthodes. L’évaluation des OOS/OOT a suivi la procédure CQ PRO 015. Les fiches de déclaration des résultats hors tendance ou non conformes obtenus lors de l’analyse au laboratoire, la description et la cause d’anomalie, le numéro de la déviation correspondante et de suivi des plans d’actions correctives et préventives (CAPA) ont été renseignées. Résultats. Les rendements, de 82,22-88,05%, étaient inférieurs à 98%. L’évaluation du poids moyen a montré des résultats conformes : 86.695-88.245 mg, pour une valeur cible de 87.500 mg. Les temps de désagrégation étaient conformes (60-637 sec), en dessous de la limite maximale de 900 sec. Il en a été de même pour le titre en Phénobarbital avec des résultats conformes de 47,80-50,80 mg/cp (moyenne 49,21 mg/cp). Deux déviations impactant deux lots ont été notées, respectivement, sur le dosage en principe actif pour le lot 2, le temps de désagrégation in process et le test de dissolution pour le lot 3 occasionnant son rejet après retraitement. Le lot 2 a fait l’objet d’une fiche OOT. Discussion. Quatre lots ont été libérés dans les 19 à 50 jours suivants leur fabrication. Huit actions correctives et préventives ont été clôturées à 100 % dans les délais. Seul le lot 3 a été rejeté après retraitement, suite à une dissolution non conforme 61% (limite 75%). Aucun lot n’a fait l’objet de réclamation, de rappel ou de retour. L’étude permet d’affirmer que le produit détient les qualités attribuées : l’évaluation du dosage en principe actif, des paramètres critiques in process, des paramètres de libération disponibles a donné des résultats conformes. Le process de fabrication a été validé.

Introduction. L’étude entre dans le cadre de valorisation des ressources de la pharmacopée africaine. Elle visait le recensement de plantes utilisées dans de la région de Thiès, centre du Sénégal, pour traiter le diabète et l'hypertension artérielle. Matériel et méthodes. Soixante-quinze (75) tradipraticiens, 78,66% d’hommes et 21,34% de femmes également répartis dans les trois départements de la région ont été interrogés sur un questionnaire et les données analysées quantitativement. Résultats. Sur 49 plantes recensées, 36,73% servaient au traitement du diabète, 26,53% à l’HTA et 36,73% pour les deux pathologies. Les plus citées furent : Sclerocarya birrea (18,05%), Combretum micrantum (16,9%), Rauwolfia vomitoria (9,98%), Catharantus roseus (7,32%), Balanites aegyptiaca (7,14%), Lonchocarpus sepium (7,35%) et Combretum glutinosum (6,62%). Les plus fréquemment prescrites étaient les mêmes : Sclerocarya birrea (15,46%), Combretum micrantum (14,9%), Rauwolfia vomitoria (8,39%), Balanites aegyptiaca (7,14%, Catharantus roseus (6%), Lonchocarpus sepium (5,84%) et Combretum glutinosum (5,84%). L’exploitation des feuilles (48,67%), racines (26,22%), fruits (15,44%), écorces (13,33%), graines (10,88%), fleurs (5,92%), bulbes (5,33%) et plantes entières (4,08%) permettait la préparation de décoctés (58,39%), d’infusés (44,28%), de poudres (18,53%), d’huiles (10,74%) essentiellement. Discussion. La position géographique de la région de Thiès, au centre du Sénégal, a permis d’enrôler des interlocuteurs de diverses ethnies pour une plus grande diversité de remèdes. Bien que nettement minoritaires, les tradipraticiennes avaient un important taux de fréquentation. Une convergence des pratiques est à noter en ce qui concerne les ressources utilisées et les préparations. La standardisation des procédures de prélèvement, de transformations et des doses administrées restent des écueils pour l’exploitation rationnelle de la Pharmacopée traditionnelle.

Il existe très peu de données cliniques françaises sur les modalités de prise en charge médicale des enfants et adolescents transgenres alors que le sujet vient très régulièrement sur le devant de la scène médiatique. Nous proposons dans cet article de décrire de manière rétrospective l'ensemble des enfants et adolescents reçus depuis 2012 dans la plus importante consultation spécialisée identité de genre enfants et adolescents d'Île-de-France. Outre leurs caractéristiques sociodémographiques, nous étudions la présence ou non d'une incongruence de genre selon les critères de la CIM 11, les vulnérabilités psychiatriques et sociales des sujets et décrivons les principales modalités de prise en charge proposées : la transition sociale, le blocage pubertaire, les transitions hormonales et/ou les rares transitions chirurgicales. Ces trois dernières propositions sont discutées en réunion de concertation pluridisciplinaire (RCP). Nous avons colligé 239 jeunes âgés de 3 à 20 ans. L'âge moyen auquel les jeunes et leur famille sont vus au premier rendez-vous est de 14,5 ans (± 3,16). Au total, 91 % de l'échantillon présentent une incongruence de genre, 32 % ayant exprimé cette incongruence avant la puberté. Deux-tiers sont des jeunes assignés de sexe féminin à la naissance (p < 0,05). En termes de psychopathologie, les troubles dépressifs et anxieux, ainsi que la suicidalité arrivent largement avant les autres cooccurrences psychiatriques. L'ostracisme et le rejet scolaire sont fréquents. Par rapport à la population adolescente générale, les jeunes de la consultation spécialisée sont beaucoup plus exposés aux discriminations et aux insultes, voire aux agressions sexuelles dans l'espace public, que leurs pairs et l'internalisation de la transphobie par ces jeunes est particulièrement importante. Au total, 40 % des jeunes ont effectué une transition sociale avant le premier rendez-vous et 74 % et 61 % d'entre elles/eux l'on fait au sein de la famille et à l'école (l'âge moyen de la transition sociale à l'école = 15,13 ans). Au total, 35 % des jeunes ont officialisé en mairie le changement de prénom (l'âge moyen = 16,26 ans). La prise de bloqueurs de puberté concerne 11 % des jeunes qui ont atteint la puberté (âge moyen = 13,9 ans, délai moyen avant instauration du traitement = 10 mois). Au total, moins de la moitié des jeunes (44 %) ont reçu un traitement hormonal masculinisant ou féminisant par hormones sexuelles (âge moyen = 16,9 ans, délai moyen avant l'instauration = 14 mois). Au total, 8,7 % des jeunes ayant reçu un traitement hormonal par hormones sexuelles ont réalisé une préservation de fertilité. Les demandes de chirurgie avant 18 ans restent très rares. Les plus fréquentes sont les torsoplasties (20 %) réalisées à l'âge moyen de 18,44 ans et jamais avant 16 ans. Les résultats de cette cohorte sont proches de ceux rapportés par d'autres centres européens pour ce qui concerne la proportion plus élevée de jeunes assignés de genre féminin à la naissance. En revanche, ils diffèrent avec des chiffres plus bas en termes de recours à des traitements hormonaux. La transition sociale est dans notre centre la demande la plus fréquente mais elle n'est pas systématique. Nous discuterons la place de la parole dans notre accompagnement pour expliquer ces différences. French clinical data on the medical management of transgender children and adolescents are scarce. Yet, the topic regularly comes to the forefront of the media. In this article, we propose to retrospectively describe all the children and adolescents received since 2012 in the largest specialized gender identity consultation for children and adolescents in Île-de-France. In addition to their sociodemographic characteristics, we study the presence or not of gender incongruence according to the ICD 11 criteria, the psychiatric and social vulnerabilities, and describe the main management modalities proposed: social transition, puberty blockage, hormonal transitions and/or rare surgical transitions. These last three proposals were discussed in multidisciplinary concertation meetings. We collected 239 youths aged 3 to 20 years. The mean age at which youth and their families were seen at the first appointment was 14.5 years (± 3.16). In all, 91% of the sample had gender incongruence, with 32% expressing gender incongruence before puberty. Two-thirds were youth assigned female at birth (P < 0.05). In terms of psychopathology, depressive and anxiety disorders, as well as suicidality, came well ahead of other psychiatric co-occurrences. School ostracism and rejection were common. Compared to the general adolescent population, the young people in the specialized consultation are much more exposed to discrimination and insults, and even sexual aggression in the public space, than their peers, and the internalization of transphobia by these young people is particularly important. In all, 40% of the young people made a social transition before the first consultation and 74% and 61% of them did so within the family and at school (the average age of social transition at school = 15.13 years). In all, 35% of the young people made the name change official at the town hall (the average age = 16.26 years). Puberty blockers were used by 11% of the youths who had reached puberty (mean age = 13.9 years, mean time to initiation = 10 months). In total, fewer than half of the youths (44%) received masculinizing or feminizing sex hormone treatment (mean age = 16.9 years, mean time to initiation = 14 months). In all, 8.7% of the young people who received sex hormone treatment underwent fertility preservation. Requests for surgery before the age of 18 remain very rare. The most frequent are torsoplasties (20%) performed at a mean age of 18.44 years and never before 16 years. The results of this cohort are close to those reported by other European centers in terms of the higher proportion of young people assigned female at birth. However, they differ with a lower proportion of hormonal treatment. Social transition is the most frequent request in our center, but it is not systematic. We wonder whether the place of narration while in our care may explain these differences. [ABSTRACT FROM AUTHOR]

This study analyzed the structure and determined the factors affecting the cost of treatment of severe burns patients. The results showed that the average total costs for a patient was 3275.9 USD. The daily cost of hospitalization was 113.3 USD, the treatment cost for 1% burn surface area was 109.5 USD with the highest proportion for medication and consumable medical equipment (43.2%), followed by surgery and procedures (30.2%). The treatment costs increased with increasing age, burn extent and deep burn area (p < .05) and were significantly higher in the group of patients with inhalation injury, electrical burns and in non-survivors (p < .01). Multivariate regression analysis found that burn extent, deep burn area and inhalation injury independently influenced the treatment cost of burn patients. [ABSTRACT FROM AUTHOR]

Antiphospholipid syndrome (APS) is a chronic autoimmune disease involving vascular thrombosis and/or obstetric morbidity and persistent antibodies to phospholipids or certain phospholipid-associated proteins. It is a rare condition in adults and even rarer in children. The diagnosis of APS can be facilitated by the use of classification criteria based on a combination of clinical and biological features. APS may be rapidly progressive with multiple, often synchronous thromboses, resulting in life-threatening multiple organ failure. This form is known as "catastrophic antiphospholipid syndrome" (CAPS). It may be primary or associated with systemic lupus erythematosus (associated APS) and in very rare cases with other systemic autoimmune diseases. General practitioners and paediatricians may encounter APS in patients with one or more vascular thromboses. Because APS is so rare and difficult to diagnosis (risk of overdiagnosis) any suspected case should be confirmed rapidly and sometimes urgently by an APS specialist. First-line treatment of thrombotic events in APS includes heparin followed by long-term anticoagulation with a VKA, usually warfarin. Except in the specific case of stroke, anticoagulants should be started as early as possible. Any temporary discontinuation of anticoagulants is associated with a high risk of thrombosis in APS. A reference/competence centre specialised in autoimmune diseases must be urgently consulted for the therapeutic management of CAPS. [ABSTRACT FROM AUTHOR]

Our study of the most representative case series of children and teenagers with thyroid cancer in Morocco (22 cases) aimed to highlight the characteristics of this cancer among children and teenagers and to compare results with those in the international literature. We conducted a retrospective, descriptive study of patients with differentiated thyroid cancer, hospitalized in the Department of Otolaryngology-Head and Neck Surgery at the Hospital in Casablanca, Morocco, over the period January 1995-March 2015. We collected data about 22 cases that met our inclusion criteria. The average age of our patients was 14 years, sex-ratio was 3.4, most of our patients presented with thyroid nodule associated, in 22.7% of cases, with cervical lymphadenopathy and in 9.1% of cases with signs of compression. All patients underwent total thyroidectomy followed by lymph node dissection in 31.82% of cases. The diagnosis of thyroid cancer was based on anatomo-pathological examination of the surgical specimen which confirmed the diagnosis of papillary carcinoma in 95.4% of cases and of vesicular carcinoma in 4.5% of cases. 100% of cases received I-131 RAI treatment followed by thyroid hormone replacement therapy. Close supervision and regular monitoring enabled the detection of nodal metastasis in 3 patients and of distance metastases in 4 patients. Differentiated thyroid cancer among children and teenagers is rare but aggressive, its treatment is based on surgery associated with iratherapy enabling excellent prognosis. [ABSTRACT FROM AUTHOR]

Jusqu'à tout récemment, la population générale avait tendance à croire qu'une femme ne pouvait être l'auteur de comportements sexuels coercitifs. Tandis qu'il est difficile d'identifier les éléments ayant pu alimenter cette croyance, il est possible que celle-ci soit associée à des conceptions erronées concernant les comportements féminins (exemple : une femme est rarement violente, elle est plutôt la cible de violences) et/ou les agressions sexuelles (exemple : une agression sexuelle consiste en un viol, cela implique nécessairement une pénétration vaginale pénienne). Cependant, la recherche a mis en évidence ces dernières années que les femmes sont aussi capables de commettre des infractions sexuelles (exemple : attouchements), seules ou avec un partenaire, parfois sous la contrainte et d'autres fois de leur propre initiative. Qui sont donc ces femmes ? Dans le cadre de cet entretien avec Jean-Pierre Bouchard, c'est à cette question qu'Alexandre Gauthier, Ingrid Ménard, Tamsin Higgs et Jonathan James tentent de répondre, en abordant : les fausses croyances entourant cette forme de délinquance et leurs impacts sur les taux de prévalence ; le profil type de la délinquante sexuelle, en distinguant celles qui agissent seules de celles qui agissent avec un partenaire ; et les principaux modèles explicatifs de cette forme de délinquance. Les chercheurs terminent en présentant les principaux paramètres à prendre en considération dans la prise en charge de ces femmes dans un contexte thérapeutique. Until recently, the general population tended to believe that a woman could not be the perpetrator of coercive sexual behavior. While it is difficult to identify what may have fueled this belief, it may be associated with misconceptions about female behavior (example: a woman is rarely violent, but rather the target of violence) and/or sexual assault (example: a sexual assault is rape, which necessarily involves penile vaginal penetration). However, research in recent years has shown that women are also capable of committing sexual offenses (example: touching), alone or with a partner, sometimes under duress and other times on their own initiative. Who are these women? During this interview with Jean-Pierre Bouchard, Alexandre Gauthier, Ingrid Ménard, Tamsin Higgs, and Jonathan James attempt to answer this question by addressing: the false beliefs surrounding this form of delinquency and their impact on prevalence rates; the typical profile of female sexual offenders, distinguishing between those who act alone and those who act with a partner; and the main explanatory models of this form of delinquency. The researchers conclude by presenting the main parameters to be considered in the management of these women in a therapeutic context. [ABSTRACT FROM AUTHOR]

L'hyper-médicalisation de nos sociétés et notre confiance sans borne envers la médecine curative nous ont fait peu à peu perdre le sens profond des mots des maux. Nombreux sont aujourd'hui ceux qui interpellent les pouvoirs publics afin que soit promue une « politique du Care ». Le recours aux anglicismes est assurément « tendance » mais opposer le « cure » et le « care » ne fait pas sens. Nous invitons le lecteur à tenter de recouvrer la signification et la valeur du verbe soigner et du mot soin(s), pluriel et pourtant si singulier. Pour mener cette quête nous porterons notre attention sur quelques œuvres d'art qui peut-être nous permettrons, en trois temps, de (re)découvrir le sens profond de la relation de soins. The hyper-medicalization of our societies and our absolute confidence in curative medicine have made us gradually lose the deep meaning of the words of ailments. Many are now calling on the public authorities to promote a "policy of Care". The use of anglicisms is certainly "trendy" but opposing "cure" and "care" does not make sense. We invite our readers to try to recover the meaning and the value of the verb to treat and the word care(s), plural and yet so singular. To carry out this quest, we will focus our attention on a few works of art which will perhaps allow us, in three stages, to (re)discover the deep meaning of the care relationship. [ABSTRACT FROM AUTHOR]

Sjögren's disease (SD), also known as Sjögren's syndrome (SS) or Gougerot-Sjögren's syndrome in France, is a rare systemic autoimmune disease in its primary form and is characterised by tropism for the exocrine glandular epithelia, particularly the salivary and lacrimal glands. The lymphocytic infiltration of these epithelia will clinically translate into a dry syndrome which, associated with fatigue and pain, constitutes the symptom triad of the disease. In about one third of patients, SD is associated with systemic complications that can affect the joints, skin, lungs, kidneys, central or peripheral nervous system, and lymphoid organs with an increased risk of B-cell lymphoma. SD affects women more frequently than men (9/1). The peak frequency is around the age of 50. However, the disease can occur at any age, with paediatric forms occurring even though they remain rare. SD can occur alone or in association with other systemic autoimmune diseases. In its isolated or primary form, the prevalence of SD is estimated to be between 1 per 1000 and 1 per 10,000 inhabitants. The most recent classification criteria were developed in 2016 by EULAR and ACR. The course and prognosis of the disease are highly variable and depend on the presence of systemic involvement and the severity of the dryness of the eyes and mouth. The current approach is therefore to identify at an early stage those patients most at risk of systemic complications or lymphoma, who require close follow-up. On the other hand, regular monitoring of the ophthalmological damage and of the dental status should be ensured to reduce the consequences. [ABSTRACT FROM AUTHOR]

Copyright of African Journal of Reproductive Health is the property of Women's Health & Action Research Centre and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Aim: To evaluate the initial results of our different treatments of open humeral shaft fractures. Method: This was a retrospective study conductecd in Abidjan (Ivory Coast) over a period of 10 years, involving 16 open humeral shaft fractures. It included 10 men and six women with a mean age of 32.8 years (Extremes: 21 and 61). The skin opening was classified according to Cauchoix and Duparc. Fractures were either treated by trimming followed by a brachial-ante-brachial cast, or treated with a screwed plate or external fixator. Patients were followed according to a strict protocol. Overall results were assessed by Stewart and hundley functional scoring. Results: At a minimum follow-up of 24 months, all patients had consolidated. There was one case of local infection, three cases of elbow stiffness and four reversible cases of radial nerve palsy. The functional results according to the Stewart and Hundley score were very good in 11 cases, good in four cases and fair in one case, with no poor result. Conclusion: Depending on the therapeutic indications, the initial results are satisfactory both clinically and functionally. [ABSTRACT FROM AUTHOR]